InvestorsHub Logo
Followers 129
Posts 2150
Boards Moderated 1
Alias Born 12/27/2007

Re: BioSpecialist post# 37

Wednesday, 01/11/2017 1:41:18 PM

Wednesday, January 11, 2017 1:41:18 PM

Post# of 236
AQSZF is close to profitability and to file 3 NDA and the whole company is valued at ridiculous $11 Million ,this stock must be the cheapest Biotech out there .Stock should be at minimum $2+ right now .

http://www.aequuspharma.ca/Investors/AQS%20investor%20November%202016_web.pdf

File for CDN approval of Topiramate XR and Oxcarbazepine XR

Operational profitability estimated in 2017

Two products launches to date (Tacrolimus IR and Vistitan™)

3 long-acting, transdermal programs in development, on track to file NDA in 2018